Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396032
Status:
COMPLETED
Last Update Posted:
2010-06-03
First Post:
2006-11-02
Brief Title:
A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
A Phase III Randomized Double-Blind Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Status:
COMPLETED
Status Verified Date:
2010-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TROPICS 3
Brief Summary:
This was a Phase III randomized double-blind placebo-controlled study conducted at 37 centers in the United States 150 subjects 16 years of age who required hemodialysis HD and had a dysfunctional HD catheter were enrolled in the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None